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for the enrichment of a cytotoxin from
Campylobacter jejuni
Xenia Gatsos1†, David L Steer1†, Thamradeen A Junaid2, A Ian Smith1, Ben Adler1 and M John Albert3*Abstract
Background: Campylobater jejuni, a major foodborne diarrhoeal pathogen is reported to produce a number of
cytotoxins of which only a cytolethal distending toxin (CDT) has been characterised so far. One or more additional
cytotoxins other than CDT, including a Chinese hamster ovary (CHO) cell active, Vero cell inactive cytotoxin, may
mediate inflammatory diarrhoea. Our objective was to develop a method to enrich and thus partially characterise
this cytotoxin, as a pathway to the eventual identification and characterisation of the toxin.
Results: A number of biochemical methods including cation- and anion-exchange chromatography were evaluated
to enrich the cytotoxin from a cell lysate of a known cytotoxin-producing C. jejuni, C31. The cytotoxin in crude
lysate was initially prepared by size-exclusion desalting and then subjected to high pressure liquid chromatography
(HPLC) ion-exchange fractionation. One pooled fraction (pool B) was cytotoxic for CHO cells equivalent to crude
toxin (tissue culture infectivity dose 50 [TCID50] of 1–2 μg/ml). The proteins of pool B were identified by mass
spectrometry (MS) after separation by SDS-PAGE and trypsin digestion. Also, pool B was directly digested with
trypsin and then subjected to liquid chromatography tandem mass spectrometry (LCMS) analysis for identification
of lesser abundant proteins in the fraction. A total of 41 proteins were found in the fraction, which included
enzymes involved in metabolic and transport functions. Eighteen non-cytoplasmic proteins including 2 major
antigenic peptide proteins (PEB2 and PEB3) and 3 proteins of unknown function were also identified in the screen.
Cytotoxicity in pool B was trypsin-sensitive indicating its protein nature. The cytotoxic activity was heat-stable to 50°
C, and partially inactivated at 60-70°C. The pool B fraction also induced fluid accumulation in the adult rabbit ileal
loop assay with cytotoxicity for mucosa confirming the presence of the cytotoxin.
Conclusions: We report the enrichment and partial purification of C. jejuni cytotoxin by HPLC ion-exchange
chromatography. Further purification may be achieved using additional complementary chromatographic
techniques. A short-list of six candidate cytotoxin proteins was identified using an LCMS screen of pool B.
Successful isolation of the cytotoxin will initiate steps for the determination of the role of this cytotoxin in the
pathogenesis of C. jejuni diarrhoea.
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Campylobacter jeuni is a foodborne pathogen and a
major cause of bacterial diarrhoea worldwide [1], yet its
pathogenicity is poorly understood. The virulence attri-
butes of C. jejuni include cell culture adherence and
invasion, flagella and motility, iron-acquisition capability
and toxin production [2]. Known toxins include a cyto-
lethal distending toxin (CDT), a cholera toxin-like en-
terotoxin (CTLT), and a number of cytotoxins [3].
However, only the genes encoding the CDT have been
identified so far [4]. There is uncertainty on the produc-
tion of CTLT by C. jejuni. Our recent work indicated
that the major outer membrane protein (MOMP-PorA)
of C. jejuni cross-reacts with cholera toxin (CT) which
would likely have misled investigators that C. jejuni
produces a CTLT [5]. It is believed that the cytotoxin(s)
may mediate inflammatory diarrhoea that is characteris-
tic of infection in individuals in developed countries [6].
One major cytotoxin is a protein-sized molecule that is
active on a number of cell lines such as HeLa and Chinese
hamster ovary (CHO), but is inactive on Vero cells [3]. A
previous report claimed that the MOMP of C. jejuni was
responsible for cytotoxicity on mammalian cells [7]. How-
ever, in our previous work, the expressed PorA protein
from the cloned gene of a cytotoxin-producing C. jejuni
strain did not have cytotoxic activity for mammalian cells
and was also devoid of diarrhoeagenic activity in an animal
model of infection [8]. In our continuing efforts to charac-
terise this unknown cytotoxin, we investigated a series of
chromatographic methods to enrich the cytotoxin from a
cytotoxic C. jejuni strain. Using previously established
methods of detection as well as further modifications to
these protocols, we have attempted to isolate and purify the
cytotoxin. The results of further characterisation studies
confirm that the likely cytotoxin candidate is a protein. The
results are reported in this communication.Figure 1 Effect of C. jejuni crude protein extract on CHO cells. Panel A
on cells upon inoculation with 4 μg crude protein extract from C. jejuni C3Results and discussion
Cytotoxicity assay
In this study, we have developed a methodology to detect
and purify the toxin potentially involved in the diarrhoea-
genic activity of C. jejuni, C31 strain. To detect and quan-
tify cytotoxic activity during purification, we used an
activity assay based on the lethal effects of the toxin on
CHO cells. The TCID50 of C31 strain for CHO cells was
similar at 1–2 μg for a freshly prepared protein extract as
well as a reconstituted form of the lyophilised extract as
estimated by the visual method by direct microscopic
observation of cytotoxic effect on cells [8] or by the indirect
methyl thiazol tetrazolium (MTT) method by spectro-
photometric measurement of formazin [9]. The cytotoxic
effect of C31 toxin on CHO cells is shown in Figure 1. The
extract was devoid of any cytotoxic effect when tested on
Vero cells as described previously [8].
Extract fractionation and cytotoxin purification
We sought to employ a series of chromatographic methods
to enrich and isolate the cytotoxin as a prelude to prote-
omic analysis to identify it. The key to this strategy was the
CHO cell cytotoxicity assay to monitor the presence of the
cytotoxin in various fractions obtained by our purification
techniques. We initially exposed the protein extract to the
various buffers and conditions likely encountered through-
out the course of the enrichment procedure to determine
which conditions were suitable for maintaining the stability
of the cytotoxin (data not shown). In these initial tests, we
found that activity was maintained in buffers containing up
to 1 M NaCl, allowing the use of ion-exchange and size-
exclusion chromatography. We also found that exposure to
low pH and organic solvents such as acetonitrile did not
reduce activity, thereby allowing the expansion of our
enrichment procedures to the use of reversed phase chro-
matography. In addition to classical chromatography, weshows appearance of normal cells and panel B shows cytotoxic effect
1 strain. Magnification x 100.
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technique, separating proteins based on their isoelectric
point into discrete fractions; however after no activity was
recovered in these experiments (data not shown),we then
focused on the use of classical chromatography.
After sample preparation using size- exclusion based
desalting, we performed cation- exchange chromatography
collecting individual fractions of which every 4 fractions
were pooled. Table 1 shows the results of the first three
pooled fractions including protein recovery in comparison
to the starting protein extract. Figure 2 shows an example
HPLC trace of the protein elution profile from the
ion-exchange column with increasing salt concentration
with the pooled collected fractions overlaid. Pool A essen-
tially consists of the first 4 minutes where no UV absor-
bance was observed, pool B consists of the weakly charged
early eluting proteins, as seen by the rise in UV absorbance.
Cytotoxic activity was also observed in pool B and this
fraction was thus used for further analysis. Pool C fractions
consisting of fractions between 8 and 12 minutes contained
some high abundance proteins as observed by the large
peaks eluting at 8 and 9 minutes.Stability of fraction B cytotoxin to protease digestion and
heat treatment
Pool B was used for further analysis as it contained the
highest level of cytotoxic activity. To further characterise
the toxin and confirm that it is a protein, we examined the
effect of protease digestion on cytotoxin activity. Incuba-
tion with trypsin reduced the toxicity of the partially puri-
fied cytotoxin for CHO cells (Figure 3). This finding likely
reflects that the cytotoxic component of the preparation is
a protein. The partially purified cytotoxin was subjected to
incubation at elevated temperatures and the observed cyto-
toxic activity was compared with the unincubated control
samples (22°C) and we found that activity was unaffected
at 50°C, but was reduced at higher temperatures (90%
active at 60°C and 70% active at 70°C) suggesting that the
cytotoxin is relatively heat- stable (data not shown).Table 1 Cytotoxic activity and recovered protein
concentration of the HPLC ion- exchange fraction pools























10-14 No 1.65Cytotoxin activity confirmation in vivo
To further confirm that the activity isolated in pool B was
due to the cytotoxin, the rabbit ileal loop assay was
employed to detect the presence of diarrhoeagenic activity.
The positive E. coli control induced a large amount of fluid
(mean volume [ml] to length of loop [cm] ratio was 2.0),
C. jejuni C31 whole cell lysate and the pool B fraction
induced moderate amounts of fluid (mean volume/length
ratio was 0.4 for C31 lysate and 0.8 for pool B fraction).
The negative control, Sorensen’s buffer, and fractions A
and C did not induce any fluid secretion. On histopath-
ology, the intestinal loops injected with the pool B fraction
or C. jejuni C31 whole lysate showed oedema, congestion,
haemorrhagic necrosis and inflammation of the mucosa
(Figure 4A), whereas the loops injected with Sorenson’s
buffer and fractions A and C appeared normal (Figure 4B).
The fluid accumulation and mucosal changes are similar to
the findings of a previous study using C. jejuni isolates
from patients with inflammatory diarrhoea [10]. This
shows that fluid secretion and mucosal inflammatory
changes are mediated by the cytotoxic pool B. Previous
studies with crude lysate of C31 showed fluid accumulation
in the rabbit ileal loop assay [8].
Proteomic identification of pool B
As the potential cytotoxin co-purified in pool B exhibited
cytotoxic activity, pool B was subjected to MS analysis for
protein identification. This was done using a combination
of SDS- PAGE and LCMS as well as the LCMS analysis of
a complete trypsin digest of pool B to identify any lesser
abundant proteins. Forty-one proteins were isolated and
identified from fraction pool B (Table 2). Of these, 23 were
predicted to reside in the cytoplasm and most have con-
served functions in metabolic processes, redox reactions,
transcription/translation control and protein processing
and turnover. BLAST searches were performed to identify
homologues or conserved domains in other species to assist
in defining a role for potential candidate cytotoxins. The
online program PSORTb was used to predict localisation of
the identified proteins. One uncharacterised protein,
A7H5H8 contains a cupin-2 domain which is characterised
by the presence of a double stranded beta helix. The func-
tion of this protein and domain are unknown, although as
it is predicted to reside in the cytoplasm, it is unlikely to be
a cytotoxin candidate.
Of the 18 non-cytoplasmic proteins identified, 7 are con-
served amongst the proteobacteria and have roles in oxida-
tion/reduction processes. Other conserved proteins are
involved in protein synthesis and turnover (A1W0L1 and
A1VYJ3), metabolism (A1VXA8, A1VXB4 and A1VZK9)
and ATP synthesis (A1VX18). Of the remaining proteins
predicted to be non-cytoplasmic, 3 are structural pro-
teins involved in flagella biosynthesis, and are unlikely
to be involved in cytotoxin biosynthesis or activity. The
minutes




Pool BPool A Pool C
Figure 2 HPLC trace of protein elution with increasing salt concentration. The trace shows the UV absorbance as milli-absorbance units
(mAU) by the eluting proteins on the y axis against time on the x axis. The gradient was run from 0 to 1 M NaCl over 30 minutes. Collected
pooled fractions are shown.
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protein interactions or are involved in binding and trans-
port of lipids (A8FKK7) or cations (A1VXM7).
A short list of six potential cytotoxin candidates is sum-
marised in Table 3. PEB3 (A1VY12) was identified in the
pool, and this protein has been previously characterised as
a glycoprotein and adhesion protein involved in transport
of phosphate-containing molecules [11]. PEB2 (A1VZC6), a
major antigenic peptide of C. jejuni on the other hand, is a
protein of unknown function which contains a similar
signal sequence to PEB3 suggesting similar localisation [12].
It is conserved in C. jejuni and C. coli and BLAST hits
return with matches to the accessory colonisation factor
protein (acfC) of Vibrio cholerae (34% identical residues/
53% positive residues) and a “Conserved Domain Search”
on NCBI matched to domains involved in extracellular




















Partially purified cytotoxic fraction B
Figure 3 Stability of cytotoxic activity of pool B to trypsin
digestion. Pool B (2 μg/ml) was treated with and without 125 μg/ml
trypsin. The samples were then incubated with CHO cells overnight.
Percent CHO cell death was determined using the MTT assay.
Experiment was performed in triplicate, error bars represent standard
error of mean (n = 3).inferences, it is unlikely to be the cytotoxin of interest, al-
though further study of this protein is warranted.
Proteins A1W0M3 and A1VZY6 are hypothetical pro-
teins and potential candidates for the cytotoxin, although
their predicted sizes (23.0 kDa and 20.5 kDa) are relatively
smaller than the high molecular weight cytotoxin pre-
viously characterised [3].
One prospective cytotoxin candidate (A1VXJ7), a 315
amino acid residue protein is a TPR family protein
which indicates that it is involved in protein:protein
interactions (residues 226–265). A tol/pal/ybgF domain
at its C-terminus (residues 235–315) is also present.
Proteins with this domain are required for stabilisation
of the outer membrane of Gram-negative bacteria. No
hypothetical functions or domains could be located to
the N-terminus (residues 1–225) of this protein. Per-
haps, the C-terminal portion allows direct contact with
a protein receptor on the host cell, and the N-terminus
contains a cytotoxin function.
The protein most likely to be involved in cytotoxic func-
tion is A8FLP3, a 412 amino acid residue protein which
contains ankyrin repeat domains near its C-terminus
(residues 180–375). A BLAST search identified mainly C.
jejuni and C. coli strains with a similar protein, and only
the ankyrin repeat domain returned hits to ankyrin repeat
domains of eukaryotes.
Ankyrin repeat domains are traditionally associated with
eukaryotic cellular functions, but more recently many intra-
cellular pathogens have been discovered to secrete (through
their T4SS) ankyrin repeat-domain containing proteins into
their hosts which act to subvert the eukaryotic host func-
tions and allow for their survival (reviewed in reference
[13]). It has been suggested that cytotoxin induced CHO
cell rounding could involve the reorganisation/inhibition of
the cytoskeletal network of the cell [14], and several
Figure 4 Histopathology of the adult rabbit intestinal loops inoculated with pool B fraction. In panel A, the loop was injected with pool B
fraction and stained with eosin and haematoxylin. The mucosa shows oedema, inflammation and necrosis. In panel B, the loop was injected with
Sorenson’s buffer (negative control) and stained with eosin and haematoxylin. The mucosa appears normal. (Magnification x 50 for both sections).
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pneumophila have the ability to interfere with
microtubule-dependent vesicle transport [15]. Per-
haps, this C. jejuni ankyrin repeat protein may also
interfere with the cytoskeletal network of CHO cells.
Further characterisation of this protein is required to
identify its function.
In this study, we have sought to isolate the protein
responsible for cytotoxic activity. We have successfully
developed a protocol to extract proteins from the lysate of
a suspension of cells retaining the activity of this protein.
We have partially purified the protein possessing cytotoxic
activity through the development of a protocol for the
preparation of the protein extract followed by fractionation
by HPLC using ion- exchange chromatography. This pro-
tocol resulted in the partial purification and enrichment of
the active protein. Further experiments will be required to
further purify the protein using chromatographic tech-
niques additional to cation- exchange, such as reversed
phase chromatography, although chromatography alone
may not be sufficient to achieve absolute purity. This how-
ever, may not be necessary as from the proteins identified
in the purified fraction, we could establish a short list of
candidate proteins and through additional experiments,
such as mutant knockout studies, confirm the identity of
the cytotoxic protein. Interestingly, the pooled fraction B
did not contain the major outer membrane protein, PorA.
This suggests that PorA is not contributing to cytotoxic
activity of fraction B [8]. We have shown that the fraction
pool B, was shown to induce fluid secretion in the rabbit
intestinal loop assay causing cytotoxic damage to the
mucosa. We further characterised the toxin showing
that, although the toxin is stable at elevated tempera-
tures (50°C), activity was reduced with increasing
temperature and activity was lost after trypsin digestion,
confirming that toxic activity is a result of a specific
protein function. However, our data do not exclude the
possibility that cytotoxic effects may be mediated by a
mixture of proteins.Guerrant et al. [16] reported that the cytotoxin is a
periplasmic protein as it can be extracted by polymyxin
B. However, in our hands, polymyxin B interfered with the
CHO cell assay, as it produced cytotoxic effects similar to
the C. jejuni cytotoxin (unpublished data).
Conclusions
Even though C. jejuni is a major foodborne diarrhoeal
pathogen causing significant morbidity and mortality, its
pathogenesis is poorly understood. It is important to purify
and characterise its major cytotoxin to define its role in
pathogenesis. We have succeeded in developing a method
(HPLC ion-exchange purification method) for enriching
and partially purifying the cytotoxin. Further studies are
required for a complete purification of the cytotoxin.
The cytotoxin may be highly active at very low concen-
trations, low enough to remain undetected by our current
proteomics identification procedures, removing most of
the contaminating proteins via sub-fractionation of the cell
should increase the chances of isolating and identifying this
cytotoxin. One other option is to purify the supernatant of
broth culture of C. jejuni, although given its fastidious
nature and slow growth rate, high levels of active cytotoxin
may be difficult to purify from the supernatant.
In this paper, we present preliminary data in our attempt
to isolate, purify and identify the protein involved in cyto-
toxic activity of C. jejuni. We have employed an activity
assay based on the lethal effects of the toxin on CHO cells
to rapidly screen for activity and used this assay to screen
chromatographic fractions to locate the presence of the ac-
tive protein. We have been unable to unequivocally identify
the protein as the sample remains too complex although
we have identified some previously uncharacterised non-
cytoplasmic proteins which with further experimentation
potentially may be attributable to the cytotoxin. We will
attempt further isolation of the protein so that we are then
able to sequence and identify the protein. The activity of
the toxin containing fraction was validated by performing
the rabbit ileal loop assay.


















Cytoplasm 353 10 4 20
A1VXN1
(cj0147c)
Thioredoxin Metabolic Cytoplasm 1931 41 4 56
A1VXS1
(Cj0193c)
Trigger factor Cell division Cytoplasm 33 1 1 2





Metabolic Cytoplasm 146 10 3 17
A1VY51
(Cj0332c)
Nucleoside diphosphate kinase Nucleotide
metabolism
Cytoplasm 80 2 1 16
A1VY53
(Cj0334)
Antioxidant, AhpC/Tsa family Cell redox
homeostasis
Cytoplasm 1762 62 6 41





Gluconeogenesis Cytoplasm 70 6 3 6
50c 4c 4c 9c
A1VYI6
(Cj0470)
Elongation factor Tu (tuf) Protein biosynthesis Cytoplasm 94 7 3 10
53c 4c 3c 10c
A1VYJ5
(Cj0479)
DNA-directed RNA polymerase subunit
beta
Transcription Cytoplasm 48 5 1 0
A1VYM1
(Cj0509c)
ATP-dependent chaperone protein ClpB Metabolic Cytoplasm 110 6 2 3
100c 6c 5c 5c
A1VZ00
(Cj0640c)
Aspartyl-tRNA synthetase (aspS) Protein biosynthesis Cytoplasm 44 3 2 6
A1VZH9
(Cj0835c)
Aconitate hydratase Metabolic Cytoplasm 97 3 2 3
127c 7c 6c 11c
A1VZR2
(Cj0929)
Cytosol aminopeptidase family protein Proteolysis Cytoplasm 68 3 1 2
39c 3c 3c 5c
A1W057
(Cj1070)
30S ribosomal protein S6 Translation Cytoplasm 226 8 1 8
A1W0G5
(Cj1181c)
Elongation factor Ts (tsf) Protein biosynthesis Cytoplasm 201 5 2 10
A1W0K3
(Cj1220)
10 kDa chaperonin (groS) Protein folding Cytoplasm 689 37 4 47
A1W0K4
(Cj1221)
60 kDa chaperonin (groL) Protein folding Cytoplasm 505 27 7 19





Metabolic Cytoplasm 38 7 3 6












679 14 4 37
A8FKM7
(Cj0440c)
Putative transcriptional regulator Transcription Cytoplasma 82 3 3 12
A1VXI8
(Cj0105)
ATP synthase subunit alpha ATP synthesis Cytoplasmic
membrane









200 7 3 9
A1W0V5
(cj1338c)
Flagellin B Flagellar motility Extracellular 2023 48 8 23
608c 25c 13c 34c
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Major antigenic peptide PEB3 Transport Non-cytoplasmic 173 4 2 11
304c 8c 6c 27c
A1VZC6
(cj0778)
Major antigenic peptide PEB2 Transport Non-cytoplasmic 233 9 3 27
159c 8c 6c 30c
A1VZK9
(Cj0866)
Arylsulfate sulfotransferase, degenerate Transferase Non-cytoplasmic 358 10 4 8
A1VZY6
(cj0998c)
Putative periplasmic protein Unknown Non-cytoplasmic 597 19 3 25
A1W0Q2
(cj1240c)







Non-cytoplasmic 200 7 3 9
292c 17c 13c 49c
A8FLP3
(cj0834c)
Putative uncharacterised protein Protein-protein
interaction
Non-cytoplasmic a 155c 8c 7c 19c
A8FKK7
(Cj0420)
Putative uncharacterised protein Lipid binding protein Non-cytoplasmic,
likely periplasmic
331 12 2 14
A1VYD4
(Cj0414)
Putative oxidoreductase subunit Oxidation-reduction
process
Non-cytoplasmicb 581 11 3 26
A1VXJ7
(cj0114)
Putative periplasmic protein Protein binding Outer membrane 174 5 1 4
A1VXA8
(Cj0029)*
L-asparaginase Metabolic Periplasm 139 3 1 4
63c 3c 3c 14c
A1VXB4 Gamma-glutamyltransferase Transferase Periplasm 575 18 6 14
303c 23c 11c 19c
A1VXC2
(Cj0037c)
Putative cytochrome C Electron carrier activity Periplasm 46 1 1 5
A1VXM7
(Cj0143c)
Putative periplasmic solute binding
protein for ABC transporter system
Metal ion binding Periplasm 36 1 1 4
A1VY79
(Cj0358)
Putative cytochrome C551 peroxidase Peroxidase Periplasm 627 33 3 13
283c 22c 13c 38c
A1W0L1
(Cj1228c)
Serine protease Proteolysis Periplasm 239 11 8 31
A8FKK2
(Cj0415)
Putative GMC oxidoreductase subunit Unknown Unknown 1830 71 16 38
286c 15c 13c 28c
*Gene designation refers to the best match identified in Campylobacter jejuni NCTC 11168 (where present).
a The programme signal was used for protein localisation prediction; non-cytoplasmic localisation refers to proteins whose localisations are unknown, but a
cytoplasmic localisation is ruled out as a N-terminal signalling sequence is present.
b The uniprot annotation was used for protein localisation prediction.
c The identification data obtained from the gel based analysis.
Prediction of protein localisation was determined using the program PSORTb, and table listings are sorted by localisation.
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Preparation of the cytotoxin and its detection
The reference cytotoxin-positive C. jejuni strain, C31 used
in our previous study was used in this study [8]. The
organism was grown on 7% sheep blood agar in a micro-
aerobic atmosphere generated with BBL gaspak (Becton
Dickinson, Sparks, MD, USA) in a jar with catalyst at
42°C for 48 h. The bacterial growth was suspended in
phosphate-buffered saline (PBS, pH, 7.2) to McFarland’s
opacity of 10 (equivalent to 3 X 109 cells). The cytotoxinwas released by sonication of bacterial cells in a sonicator
(Soniprep 150 MSE, London,United Kingdom) at 10 amp-
litude microns for 20 min. The lysed cell suspension was
centrifuged at 12,000 rpm at 4°C for 15 min in a Beckman
centrifuge (J2-M1 with JA 20 rotor) and the supernatant
was filtered through a sterile Techno Plastic Products
(TPP, Zollstrasse, Switzerland) membrane filter (0.22 μm
pore diameter). The fresh filtrate and the filtrate after
freeze-drying were tested on Chinese hamster ovary
(CHO) cells as described previously [8]. Doubling serial
Table 3 Short-list of potential cytotoxin candidates identified from LCMS screen of pool B
Accession number Full identification name Biological function known or inferred localisation Size (kDa)
A1VY12 (cj0289c)* Major antigenic peptide PEB3 Transport Non-cytoplasmic 27.5
A1VZC6 (cj0778) Major antigenic peptide PEB2 Transport Non-cytoplasmic 27.0
A8FLP3 (cj0834c) Putative uncharacterised protein Protein-protein interaction Non-cytoplasmic a(signalP) 46.7
A1W0M3 (cj1240c) Putative periplasmic protein Protein binding Non-cytoplasmic 23.0
A1VZY6 (cj0998c) Putative periplasmic protein Unknown Non-cytoplasmic 20.5
A1VXJ7 (cj0114) Putative periplasmic protein Protein binding Outer membrane 35.4
*Gene designation refers to the best match identified in Campylobacter jejuni NCTC 11168.
a Protein localisation prediction was determined using the program signalP.
Prediction of protein localisation was determined using the program PSORTb.
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United Kingdom) with a starting dilution of 1:2 were
tested. Cytotoxic activity was characterised by cell
rounding, granulation and eventual sloughing. The
toxin titre was expressed as tissue culture infectivity 50
(TCID50) dose, the concentration of the toxin that caused
cytotoxicity in 50% of the monolayer. In some instances,
we used the methyl thiazol tetrazolium (MTT) assay [9] to
quantitate cytotoxin activity. Metabolically active CHO
cells are able to reduce the formazin present in the MTT
reagent resulting in a colour change, allowing spectro-
photometric quantitation of the activity of the cytotoxin.
Results were calculated as a percentage of cell death
when compared to a control using the equation: 1-(test
well/control well) ×100. The experiment was per-
formed in biological triplicates. The Students t-test
was used for statistical analysis; a P value of ≤0.05 was
considered significant.
The effect of cytotoxin on Vero cell was investigated
as described previously [8].Fractionation of cytotoxin with OFFGEL electrophoresis
Fractionation was done using the Agilent OFFGEL Frac-
tionator (Agilent Technologies, Santa Clara, CA, USA).
The toxin preparation (freeze-dried and reconstituted in
distilled water) was desalted using the 2D cleanup kit
according to manufacturer’s instructions (GE Healthcare
Biosciences, AB, Uppsala, Sweden) and the precipitated
protein was reconstituted in the OFFGEL running buffer.
The sample was then fractionated using a 13 cm, 3–10 pH
range IPG strip collecting 12 fractions according to the
manufacturer’s instructions.Sample preparation for HPLC ion- exchange fractionation
Typically 100 mg of extract was reconstituted in 100 μl
water, centrifuged to remove insoluble material and
desalted using size-exclusion (SE) based device, the Zeba
Spin desalting column (Pierce, Rockford, IL, USA)
according to manufacturer’s instructions.HPLC ion- exchange fractionation
HPLC purification was performed on an 1100 series mi-
crobore HPLC (Agilent technologies). The preparation
obtained from the SE spin column was diluted to 500 μl in
Soreneson’s buffer, pH 7.4 (Buffer A). Samples were
injected onto an ion-exchange column Mono Q HR 5/5
(GE Healthcare Biosciences) with buffer A at a flow rate of
150 μl/minute. The proteins were eluted over a 30-minute
linear gradient to 100% B (Sorenson’s buffer, pH 7.4, 1 M
NaCl). Fractions were collected at 1 minute intervals and
every four fractions were pooled. Pooled fractions were
concentrated to 500 μl using nanosep 10 k cutoff centri-
fugal device (Pall Life Sciences, MI, USA). In preparation
for the MTT assay, the resultant fractions were diluted to
2 ml volumes with Sorenson’s buffer.
Mass spectrometry (MS)
Trypsin digests on excised gel bands were performed in a
solution of 20 mM ammonium bicarbonate containing
0.5 μg trypsin (Promega corporation, Madison, WI, USA)
and then analysed directly by LCMS as outlined below.
Trypsin digests on the pool B fraction directly were per-
formed in a solution of 20 mM ammonium bicarbonate
containing 10 μg trypsin (Promega corporation) and then
the resultant digested peptides were fractionated by 12 salt
plug elutions ranging from 2 mM to 500 mM NaCl from a
SCX TopTip (Glygen, Columbia, MD, USA) according to
manufacturer’s instruction. Both digest protocols were
incubated at 37°C for 12 hours. Tryptic digests were
analysed by LC-MS/MS using the HCT ULTRA ion trap
mass spectrometer (Bruker Daltonics, Bremen, Germany)
coupled online with a 1200 series capillary HPLC (Agilent
technologies). Samples were injected onto a zorbax 300SB
reversed phase column with buffer A (5% acetonitrile 0.1%
formic acid) at a flow rate of 10 μl/minute. The peptides
were eluted over a 30-minute gradient to 55% B (90%
acetonitrile 0.1% formic acid). The eluant was nebulised
and ionised using the Bruker electrospray source using the
low flow electrospray needle with a capillary voltage of
4000 V dry gas at 300°C, flow rate of 8 l/minute and nebu-
liser gas pressure at 1500 mbar. Peptides were selected for
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settings selected and active exclusion released after
1 minute.
Data from LCMSMS runs were processed using Data
Analysis 3.4 (Bruker Daltonics) and were exported in
Mascot generic file format (*.mgf) and searched against
an in-house database comprised of C. jejuni FASTA
format genomes downloaded from the National Center
for Biotechnology Information (NCBI) FTP site using
the MASCOT search engine (version 2.1, Matrix Science
Inc., London, United Kingdom) using MUDPIT scoring.
The mgf files from the salt plug elutions were combined
into a single mgf file. The following search parameters
were used: missed cleavages, 1; peptide mass tolerance,
± 0.4 Da; peptide fragment tolerance, ± 0.2 Da; peptide
charge, 2+ and 3+; fixed modifications, carbamido-
methyl; variable modification, oxidation (Met).
Stability of cytotoxin to protease digestion
The cytotoxin in pool B fraction was treated with trypsin
(125 μg/ml) (Sigma, St. Louis, MO, USA) for 4 h at 37°C.
The trypsin was inactivated by the addition of 125 μg/ml
soybean trypsin inhibitor (Sigma). One hundred mi-
croliters of treated pool B fractions at a concentration of
2 μg/ml were added to a CHO cell monolayer in a micro-
titre plate. The MTT assay [9] for cytotoxicity was per-
formed after a 24 h incubation period. Control samples
consisted of PBS and trypsin inhibitor and were used in the
calculation of percent cell death. The experiment was per-
formed in triplicate and the Students t-test used to deter-
mine statistical significance.
Heat stability of the cytotoxin
Triplicate samples of the cytotoxin in pool B fraction
extract were incubated at 50°C, 60°C, or 70°C, for 30 min.
The MTTassay was then performed for cytotoxicity [9].
Rabbit ileal loop assay of pool B fraction for
diarrhoeagenic activity
The ability of pool B fraction to induce fluid accumulation
and cause inflammatory changes in the mucosa was studied
in the adult rabbit ileal loop assay [10]. The concentration
of the fraction B tested was 0.2 mg/ml, and 1.0 ml of the
fraction was inoculated into single small intestinal loops
(approximately 10 cm long) of two adult rabbits. A similar
concentration of fraction A and fraction C was also tested.
The negative control loop was inoculated with Sorensen’s
buffer (diluent used to dissolve the toxin) and the positive
control loops were inoculated with a whole lysate of C.
jejuni C31 strain [8] or a broth culture of enterotoxigenic
Escherichia coli (strain H10407). After 20 h of inoculation,
the rabbits were sacrificed, the characteristics and amount
of fluid accumulated noted and tissue sections taken in
neutral formal saline for processing for histopathology bystaining with eosin and haematoxylin stain. Coded slides
were examined by a histopathologist.
The procedures involving animals were according to
the guidelines for animal research of the Health Sciences
Centre, Kuwait University.
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